---
title: "Advanced Biomed Inc. (ADVB.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADVB.US.md"
symbol: "ADVB.US"
name: "Advanced Biomed Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T06:03:02.501Z"
locales:
  - [en](https://longbridge.com/en/quote/ADVB.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADVB.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADVB.US.md)
---

# Advanced Biomed Inc. (ADVB.US)

## Company Overview

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.advanbiomed.com](https://www.advanbiomed.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 1.37 | 2 | 1.78 | 1.48 | 1.31 |
| PB | 0.78 | 7 | 3.03 | 2.44 | 0.81 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ADVB.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ADVB.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ADVB.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ADVB.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**